Novartis Capital P Bond Technical Analysis
| 66989HAR9 | 83.96 4.56 5.15% |
As of the 1st of December, NOVARTIS secures the Risk Adjusted Performance of (0.07), mean deviation of 0.5225, and Market Risk Adjusted Performance of 7.08. Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of NOVARTIS CAPITAL P, as well as the relationship between them.
NOVARTIS Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NOVARTIS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NOVARTISNOVARTIS |
NOVARTIS technical bond analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, bond market cycles, or different charting patterns.
NOVARTIS CAPITAL P Trend Analysis
Use this graph to draw trend lines for NOVARTIS CAPITAL P. You can use it to identify possible trend reversals for NOVARTIS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NOVARTIS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.NOVARTIS Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NOVARTIS CAPITAL P applied against its price change over selected period. The best fit line has a slop of 0.09 , which may suggest that NOVARTIS CAPITAL P market price will keep on failing further. It has 122 observation points and a regression sum of squares at 297.66, which is the sum of squared deviations for the predicted NOVARTIS price change compared to its average price change.About NOVARTIS Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NOVARTIS CAPITAL P on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NOVARTIS CAPITAL P based on its technical analysis. In general, a bottom-up approach, as applied to this corporate bond, focuses on NOVARTIS CAPITAL P price pattern first instead of the macroeconomic environment surrounding NOVARTIS CAPITAL P. By analyzing NOVARTIS's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NOVARTIS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NOVARTIS specific price patterns or momentum indicators. Please read more on our technical analysis page.
NOVARTIS December 1, 2024 Technical Indicators
Most technical analysis of NOVARTIS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NOVARTIS from various momentum indicators to cycle indicators. When you analyze NOVARTIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 7.08 | |||
| Mean Deviation | 0.5225 | |||
| Coefficient Of Variation | (1,037) | |||
| Standard Deviation | 1.17 | |||
| Variance | 1.37 | |||
| Information Ratio | (0.21) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | 7.07 | |||
| Maximum Drawdown | 8.9 | |||
| Value At Risk | (1.28) | |||
| Potential Upside | 0.4298 | |||
| Skewness | 0.8075 | |||
| Kurtosis | 14.1 |
Other Information on Investing in NOVARTIS Bond
NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.